| scholarly article | Q13442814 |
| P2093 | author name string | Yen TS | |
| Liang H | |||
| Coyne MY | |||
| Greer CE | |||
| Ralston R | |||
| Langenberg A | |||
| Wheeler CM | |||
| Beutner K | |||
| Ladner MB | |||
| P2860 | cites work | Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center | Q72594564 |
| Dual infection with human papillomavirus in a population with overt genital condylomas | Q72954370 | ||
| Molecular cloning and expression of a G25K cDNA, the human homolog of the yeast cell cycle gene CDC42 | Q24596620 | ||
| Immunological sex differences. A study of patients with rheumatoid arthritis, their relatives, and controls | Q33626674 | ||
| Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11 | Q33930770 | ||
| Sex differences in response to hepatitis B infection among patients receiving chronic dialysis treatment | Q35065120 | ||
| Polymerase chain reaction-based methods for the detection of human papillomavirus DNA | Q35235279 | ||
| Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action | Q35835114 | ||
| Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation | Q36272077 | ||
| Structural polypeptides of rabbit, bovine, and human papillomaviruses | Q36535294 | ||
| Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions | Q36682801 | ||
| Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles | Q36685977 | ||
| Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope. | Q36780785 | ||
| Laboratory production in vivo of infectious human papillomavirus type 11 | Q36884907 | ||
| A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. | Q37604389 | ||
| Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women | Q37889036 | ||
| Effects of gender and sex steroids on the immune response | Q38147161 | ||
| Seroepidemiological studies of human papilloma virus (HPV-1) infections | Q40129198 | ||
| Human pathogenic papillomavirus types: an update | Q40763787 | ||
| Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia | Q40854169 | ||
| Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles | Q41019646 | ||
| Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata | Q41151354 | ||
| DNA sequence and genome organization of genital human papillomavirus type 6b | Q41467261 | ||
| HPV-1 Capsids Expressed in Vitro Detect Human Serum Antibodies Associated with Foot Warts | Q41540444 | ||
| HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions | Q41605855 | ||
| Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts | Q44256158 | ||
| Genital Human Papillomavirus Infection in Female University Students as Determined by a PCR-Based Method | Q44295934 | ||
| Measles antibodies as related to HL-A types in multiple sclerosis | Q44515899 | ||
| Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine | Q45775340 | ||
| Purification of bovine papilloma virus by gel filtration on Sephacryl S-1000 superfine | Q45799125 | ||
| Interactions between the gonadal steroids and the immune system | Q46261265 | ||
| A sex difference in immunologic responsiveness | Q47760254 | ||
| Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses | Q48078217 | ||
| Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms | Q48078227 | ||
| Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions | Q52477431 | ||
| Detection of human papillomavirus capsid antigens in various squamous epithelial lesions using antibodies directed against the L1 and L2 open reading frames. | Q54125020 | ||
| Antibody response to a synthetic peptide derived from the human papillomavirus type 6/11 L2 protein in recurrent respiratory papillomatosis: Correlation between southern blot hybridization, polymerase chain reaction, and serology | Q58035411 | ||
| Evolution of the antibody response to human papillomavirus type 11 (HPV-11) in patients with condyloma acuminatum according to treatment response. | Q64889252 | ||
| Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP) | Q67487673 | ||
| Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1 | Q67654383 | ||
| Human papillomavirus in exophytic condylomatous lesions on different female genital regions | Q68252395 | ||
| Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins | Q68450753 | ||
| Incidence of antibodies to human papillomavirus type 1 in patients with cutaneous and mucosal papillomas | Q68486620 | ||
| Persistence of type-specific human papillomavirus infection among cytologically normal women | Q72238714 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| Papillomavirus | Q1137717 | ||
| sexual transmission | Q45349134 | ||
| P304 | page(s) | 2058-2063 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts | |
| P478 | volume | 33 |
| Q35606837 | A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011 |
| Q40042359 | A sequential logit model of caretakers' decision to vaccinate children for the human papillomavirus virus in the general population |
| Q36983254 | A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States |
| Q33599028 | Acceptability of HPV vaccine among a national sample of gay and bisexual men. |
| Q36534239 | Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis |
| Q44046271 | Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands |
| Q40007772 | Awareness of Human Papillomavirus Vaccine Among Adolescent African American Males Who Have Sex with Males: a Pilot Study. |
| Q40210151 | Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity |
| Q36584357 | Chapter 13: Current findings from prophylactic HPV vaccine trials |
| Q35533572 | Circumcision and acquisition of human papillomavirus infection in young men. |
| Q37000894 | Circumcision and human papillomavirus infection in men: a site-specific comparison |
| Q35235306 | Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model |
| Q30411042 | Concordance of human papillomavirus types detected on the surface and in the tissue of genital lesions in men. |
| Q37687207 | Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran |
| Q40063569 | Cost-effectiveness of human papillomavirus vaccination in Germany |
| Q37009015 | Cost-effectiveness of human papillomavirus vaccination in the United States |
| Q34698919 | Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata |
| Q34089078 | Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report |
| Q35049980 | Early cervical neoplasia: advances in screening and treatment modalities |
| Q34605012 | Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review |
| Q34155973 | Effects of information framing on human papillomavirus vaccination |
| Q33810515 | Efficacy of Human Papillomavirus L1 Protein Vaccines (Cervarix and Gardasil) in Reducing the Risk of Cervical Intraepithelial Neoplasia: A Meta-analysis |
| Q33488325 | Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model |
| Q35944640 | Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection |
| Q34347005 | Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study |
| Q28750269 | Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial |
| Q38647798 | Functional characterization of CD4 and CD8 T cell responses among human papillomavirus infected patients with ano-genital warts |
| Q35957926 | Gender differences among low income women in their intent to vaccinate their sons and daughters against human papillomavirus infection |
| Q35433608 | Genital and extra-genital warts increase the risk of asymptomatic genital human papillomavirus infection in men. |
| Q36353396 | Genital human papillomavirus infection in men. |
| Q33772672 | Geographic variation in human papillomavirus vaccination uptake among 13-17 year old adolescent girls in the United States |
| Q51872384 | HPV awareness and vaccine acceptability in hispanic women living along the US-Mexico border. |
| Q36252874 | HPV prophylactic vaccination in males improves the clearance of semen infection |
| Q36998569 | HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis. |
| Q35219566 | Higher prevalence of sexual transmitted diseases and correlates of genital warts among heterosexual males attending sexually transmitted infection clinics (MSCs) in Jiangmen, China: implication for the up-taking of STD related service |
| Q51773194 | Human Papillomavirus Vaccination Among Young Adult Gay and Bisexual Men in the United States. |
| Q93265992 | Human Papillomavirus Vaccination and Anogenital Warts: A Systematic Review of Impact and Effectiveness in the United States |
| Q33774640 | Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types |
| Q36972160 | Human papillomavirus infection: epidemiology and pathophysiology |
| Q33638299 | Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men |
| Q36972163 | Human papillomavirus vaccination in males |
| Q35836651 | Human papillomavirus vaccine policies among american Indian tribes in Washington State |
| Q35231562 | Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008 |
| Q37363411 | Human papillomavirus--lessons from history and challenges for the future |
| Q35562265 | Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection |
| Q41103016 | Immunology of papillomavirus infection. |
| Q35532844 | Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. |
| Q40138686 | Incidence and risk factors for human papillomavirus infections in young female online daters. |
| Q35945178 | Increasing incidence of anogenital warts with an urban-rural divide among males in Manitoba, Canada, 1990-2011. |
| Q37712999 | Inhibition by cellular vacuolar ATPase impairs human papillomavirus uncoating and infection |
| Q35891056 | Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts. |
| Q24802323 | Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant |
| Q39868889 | Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China |
| Q55425847 | L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine. |
| Q35205476 | Management strategies and cost effectiveness in the prevention of cervical cancer |
| Q33600831 | Men's beliefs about HPV-related disease |
| Q47100852 | Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico |
| Q37133594 | Molecular epidemiology of human papillomavirus |
| Q37316158 | Oncogenic activities of human papillomaviruses |
| Q33632759 | Papillomavirus-like particle vaccines for cervical cancer |
| Q44182045 | Papillomaviruses: prophylactic vaccine prospects |
| Q59397134 | Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention |
| Q39412809 | Perceptions and acceptability of HPV vaccination among parents of young adolescents: a multicenter national survey in China. |
| Q74607911 | Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts |
| Q80439545 | Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece |
| Q64904083 | Prevalence and distribution of HPV types in genital warts in Xi'an, China: a prospective study. |
| Q60918621 | Prevalence and incidence of genital warts and cervical Human Papillomavirus infections in Nigerian women |
| Q36134618 | Prevalence and seroprevalence of low-risk human papillomavirus in Korean women |
| Q34343006 | Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine |
| Q36082663 | Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women |
| Q35984558 | Prophylactic HPV vaccines |
| Q24545449 | Prophylactic human papillomavirus vaccines |
| Q35196463 | Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13- to 17-year-old U.S. adolescent children |
| Q37349077 | Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study |
| Q35886559 | Regional variations in HPV vaccination among 9-17 year old adolescent females from the BRFSS, 2008-2010. |
| Q54765914 | Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. |
| Q33345224 | Seroprevalence of 34 human papillomavirus types in the German general population |
| Q33600592 | Statewide HPV vaccine initiation among adolescent females in North Carolina |
| Q56959542 | Strategies for immunoprophylaxis and immunotherapy of papillomaviruses |
| Q97528833 | Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development |
| Q89845622 | The Conundrum of an Accumulating Acuminatum |
| Q34606628 | The HPV vaccine and the media: how has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? |
| Q80462054 | The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada |
| Q37284008 | The role of NH4Cl and cysteine proteases in Human Papillomavirus type 16 infection |
| Q38839706 | The safety and immunogenicity of Quadrivalent HPV (qHPV) vaccine in systemic lupus erythematosus |
| Q33517490 | Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples |
| Q41485282 | Tissue xenografts as a model system for study of the pathogenesis of papillomaviruses |
| Q34812959 | Towards the eradication of HPV infection through universal specific vaccination |
| Q43961793 | Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom |
| Q37505423 | Using risk to target HPV vaccines in high-risk, low-resource organizations |
| Q38088523 | Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development |
| Q37626665 | Well-woman visit of mothers and human papillomavirus vaccine intent and uptake among their 9-17 year old children |
Search more.